AMERIPRISE FINANCIAL INC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$198,940
-11.7%
98,0000.0%0.00%
Q2 2023$225,400
-24.9%
98,000
-1.1%
0.00%
Q1 2023$300,273
+38.4%
99,100
+6.6%
0.00%
Q4 2022$217,000
-16.5%
93,000
-31.8%
0.00%
Q3 2022$260,000
-10.3%
136,300
+27.4%
0.00%
Q2 2022$290,000
-10.5%
107,000
-1.8%
0.00%
Q1 2022$324,000
-21.0%
108,907
+3.3%
0.00%
Q4 2021$410,000
+48.0%
105,386
+63.2%
0.00%
Q3 2021$277,000
+39.2%
64,561
-1.6%
0.00%
Q2 2021$199,000
-62.0%
65,621
-58.2%
0.00%
Q1 2021$523,000
-76.9%
157,028
-75.4%
0.00%
-100.0%
Q4 2020$2,262,000
+10.2%
637,292
-2.8%
0.00%0.0%
Q3 2020$2,052,000
+107.9%
655,499
+527.2%
0.00%
Q3 2018$987,000
+1956.2%
104,506
+682.9%
0.00%
Q2 2017$48,000
-73.2%
13,349
-75.7%
0.00%
Q1 2017$179,000
+29.7%
54,958
-2.4%
0.00%
Q4 2016$138,000
-38.7%
56,328
-14.0%
0.00%
Q3 2016$225,000
-3.0%
65,481
-1.8%
0.00%
Q2 2016$232,000
-16.8%
66,677
-1.2%
0.00%
Q1 2016$279,000
-7.9%
67,471
-0.8%
0.00%
Q4 2015$303,000
+74.1%
68,033
+138.4%
0.00%
Q3 2015$174,00028,5410.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2020
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 340,000$1,459,0000.53%
RTW INVESTMENTS, LP 4,733,323$20,306,0000.31%
APIS CAPITAL ADVISORS, LLC 70,000$300,0000.29%
Hudson Bay Capital Management LP 1,800,000$7,722,0000.10%
COWEN AND COMPANY, LLC 249,215$1,069,0000.05%
Kerrisdale Advisers, LLC 100,000$429,0000.05%
Woodline Partners LP 496,172$2,129,0000.04%
Shay Capital LLC 60,000$257,0000.03%
Walleye Capital LLC 231,037$991,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 212,700$912,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders